Filing Details

Accession Number:
0002007919-24-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-07 18:05:13
Reporting Period:
2024-06-05
Accepted Time:
2024-06-07 18:05:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
2007919 Inhibrx Biosciences Inc. INBX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366268 Faiz Jon Kayyem C/O Inhibrx, Inc.
11025 North Torrey Pines Road, Suite 200
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-05 49,284 $17.23 1,142,145 No 4 P Indirect By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Common Stock Acquisiton 2024-06-05 8,265 $17.89 1,150,410 No 4 P Indirect By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
No 4 P Indirect By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Footnotes
  1. The shares were purchased in multiple transactions at prices ranging from $16.81 to $17.805, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The shares were purchased in multiple transactions at prices ranging from $17.81 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.